Allianz Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $32.6M | Sell |
178,049
-69,673
| -28% | -$12.8M | 0.03% | 459 |
|
|
2025
Q4 | $43.6M | Sell |
247,722
-149,081
| -38% | -$24.4M | 0.04% | 372 |
|
|
2025
Q3 | $55.6M | Sell |
396,803
-130,257
| -25% | -$17.6M | 0.06% | 302 |
|
|
2025
Q2 | $66.2M | Sell |
527,060
-140,707
| -21% | -$17.5M | 0.08% | 243 |
|
|
2025
Q1 | $91.4M | Buy |
667,767
+131,813
| +25% | +$18.8M | 0.12% | 162 |
|
|
2024
Q4 | $82M | Buy |
535,954
+10,441
| +2% | +$1.76M | 0.11% | 198 |
|
|
2024
Q3 | $102M | Sell |
525,513
-2,665
| -0.5% | -$558K | 0.14% | 154 |
|
|
2024
Q2 | $122M | Sell |
528,178
-92,066
| -15% | -$20M | 0.18% | 117 |
|
|
2024
Q1 | $134M | Sell |
620,244
-98,475
| -14% | -$23.1M | 0.21% | 113 |
|
|
2023
Q4 | $186M | Sell |
718,719
-53,639
| -7% | -$13.2M | 0.3% | 64 |
|
|
2023
Q3 | $199M | Buy |
772,358
+20,147
| +3% | +$5.39M | 0.33% | 49 |
|
|
2023
Q2 | $214M | Buy |
752,211
+52,942
| +8% | +$15.8M | 0.38% | 45 |
|
|
2023
Q1 | $194M | Buy |
699,269
+117,635
| +20% | +$32.5M | 0.34% | 54 |
|
|
2022
Q4 | $161M | Buy |
581,634
+16,703
| +3% | +$4.72M | 0.31% | 67 |
|
|
2022
Q3 | $151M | Sell |
564,931
-32,754
| -5% | -$6.96M | 0.31% | 67 |
|
|
2022
Q2 | $122M | Buy |
597,685
+66,903
| +13% | +$13.7M | 0.12% | 192 |
|
|
2022
Q1 | $112M | Buy |
530,782
+62,913
| +13% | +$13.7M | 0.08% | 256 |
|
|
2021
Q4 | $112M | Buy |
467,869
+155,845
| +50% | +$40.1M | 0.08% | 276 |
|
|
2021
Q3 | $88.3M | Buy |
312,024
+109,683
| +54% | +$35.9M | 0.07% | 293 |
|
|
2021
Q2 | $70.1M | Sell |
202,341
-30,680
| -13% | -$9.29M | 0.06% | 307 |
|
|
2021
Q1 | $65.2M | Sell |
233,021
-121,533
| -34% | -$32.8M | 0.06% | 308 |
|
|
2020
Q4 | $86.8M | Buy |
354,554
+48,058
| +16% | +$12.4M | 0.09% | 236 |
|
|
2020
Q3 | $86.9M | Sell |
306,496
-299,460
| -49% | -$83.5M | 0.1% | 206 |
|
|
2020
Q2 | $162M | Buy |
605,956
+23,302
| +4% | +$7M | 0.19% | 117 |
|
|
2020
Q1 | $184M | Sell |
582,654
-51,071
| -8% | -$15.5M | 0.25% | 93 |
|
|
2019
Q4 | $188M | Buy |
633,725
+66,855
| +12% | +$18.5M | 0.17% | 125 |
|
|
2019
Q3 | $132M | Sell |
566,870
-63,204
| -10% | -$14.7M | 0.13% | 173 |
|
|
2019
Q2 | $147M | Sell |
630,074
-48,065
| -7% | -$11.1M | 0.14% | 158 |
|
|
2019
Q1 | $160M | Buy |
678,139
+21,839
| +3% | +$6.88M | 0.16% | 132 |
|
|
2018
Q4 | $197M | Buy |
656,300
+92,416
| +16% | +$29.5M | 0.22% | 98 |
|
|
2018
Q3 | $199M | Sell |
563,884
-136,332
| -19% | -$46.9M | 0.18% | 110 |
|
|
2018
Q2 | $203M | Sell |
700,216
-81,982
| -10% | -$23M | 0.2% | 99 |
|
|
2018
Q1 | $214M | Buy |
782,198
+152,461
| +24% | +$47.3M | 0.2% | 94 |
|
|
2017
Q4 | $201M | Buy |
629,737
+67,044
| +12% | +$21.5M | 0.16% | 126 |
|
|
2017
Q3 | $176M | Buy |
562,693
+23,796
| +4% | +$7.05M | 0.15% | 133 |
|
|
2017
Q2 | $146M | Buy |
538,897
+3,670
| +0.7% | +$970K | 0.14% | 159 |
|
|
2017
Q1 | $146M | Sell |
535,227
-183,046
| -25% | -$51.8M | 0.14% | 148 |
|
|
2016
Q4 | $204M | Buy |
718,273
+17,447
| +2% | +$5.17M | 0.18% | 114 |
|
|
2016
Q3 | $218M | Sell |
700,826
-149,046
| -18% | -$44.1M | 0.21% | 88 |
|
|
2016
Q2 | $206M | Sell |
849,872
-8,680
| -1% | -$2.29M | 0.22% | 95 |
|
|
2016
Q1 | $223M | Buy |
858,552
+51,992
| +6% | +$13.7M | 0.25% | 80 |
|
|
2015
Q4 | $247M | Sell |
806,560
-86,111
| -10% | -$24.7M | 0.28% | 71 |
|
|
2015
Q3 | $260M | Sell |
892,671
-120,508
| -12% | -$39.8M | 0.31% | 66 |
|
|
2015
Q2 | $409M | Buy |
1,013,179
+121,307
| +14% | +$48.7M | 0.44% | 41 |
|
|
2015
Q1 | $377M | Buy |
891,872
+62,413
| +8% | +$24.6M | 0.43% | 51 |
|
|
2014
Q4 | $282M | Sell |
829,459
-189,774
| -19% | -$61.4M | 0.31% | 68 |
|
|
2014
Q3 | $337M | Sell |
1,019,233
-39,053
| -4% | -$12.9M | 0.41% | 55 |
|
|
2014
Q2 | $334M | Buy |
1,058,286
+52,803
| +5% | +$15.9M | 0.42% | 55 |
|
|
2014
Q1 | $308M | Buy |
1,005,483
+11,810
| +1% | +$3.75M | 0.37% | 59 |
|
|
2013
Q4 | $278M | Sell |
993,673
-39,962
| -4% | -$10.3M | 0.35% | 63 |
|
|
2013
Q3 | $249M | Sell |
1,033,635
-105,525
| -9% | -$23.6M | 0.33% | 71 |
|
|
2013
Q2 | $245M | Buy |
+1,139,160
| New | +$243M | 0.35% | 66 |
|
Other funds holding BIIB
VCM
VPM
Allianz Asset Management's BIIB Position: Q1 2026 in Review
Allianz Asset Management reduced its Biogen (BIIB) stake by 28% in Q1 2026, selling an estimated $12.8M and leaving 178,049 shares worth $32.6M. The position accounts for 0.03% of the portfolio, ranked #459.
Allianz Asset Management first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $409M in Q2 2015. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Allianz Asset Management held 178,049 shares of Biogen worth $32.6M as of Q1 2026.
- Allianz Asset Management sold 69,673 Biogen shares in Q1 2026, an estimated $12.8M.
- Biogen made up 0.03% of Allianz Asset Management's portfolio in Q1 2026, its #459 holding.
- Allianz Asset Management first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
- Allianz Asset Management's Biogen position peaked at $409M in Q2 2015.
- 1,003 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.